Drug Delivery Strategies for Insoluble Drugs

吕祎凡,陆伟跃,潘俊

2009-01-01

Abstract:Many new active drugs have poor solubility in vivo. This challenges pharmaceuticals to increase the drug solubility and improve the bioavailability. This article reviews the emerging formulation designs for delivering of poorly water-soluble drugs.

What problem does this paper attempt to address?

Insoluble drug delivery strategies: review of recent advances and business prospects

Sandeep Kalepu,Vijaykumar Nekkanti

DOI: https://doi.org/10.1016/j.apsb.2015.07.003

IF: 14.903

2015-09-01

Acta Pharmaceutica Sinica B

Abstract:The emerging trends in the combinatorial chemistry and drug design have led to the development of drug candidates with greater lipophilicity, high molecular weight and poor water solubility. Majority of the failures in new drug development have been attributed to poor water solubility of the drug. Issues associated with poor solubility can lead to low bioavailability resulting in suboptimal drug delivery. About 40% of drugs with market approval and nearly 90% of molecules in the discovery pipeline are poorly water-soluble. With the advent of various insoluble drug delivery technologies, the challenge to formulate poorly water soluble drugs could be achieved. Numerous drugs associated with poor solubility and low bioavailabilities have been formulated into successful drug products. Several marketed drugs were reformulated to improve efficacy, safety and patient compliance. In order to gain marketing exclusivity and patent protection for such products, revitalization of poorly soluble drugs using insoluble drug delivery technologies have been successfully adopted by many pharmaceutical companies. This review covers the recent advances in the field of insoluble drug delivery and business prospects.

pharmacology & pharmacy
Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules

Qi Li,Xiaosi Li,Chao Zhao

DOI: https://doi.org/10.3389/fbioe.2020.00437

IF: 5.7

2020-05-13

Frontiers in Bioengineering and Biotechnology

Abstract:The therapeutic effect of small hydrophilic molecules is limited by the rapid clearance from the systemic circulation or a local site of administration. The unsuitable pharmacokinetics and biodistribution can be improved by encapsulating them in drug delivery systems. However, the high-water solubility, very hydrophilic nature, and low molecular weight make it difficult to encapsulate small hydrophilic molecules in many drug delivery systems. In this mini-review, we highlight three strategies to efficiently encapsulate small hydrophilic molecules and achieve controlled release: physical encapsulation in micro/nanocapsules, physical adsorption via electronic interactions, and covalent conjugation. The principles, advantages, and disadvantages of each strategy are discussed. This review paper could be a guide for scientists, engineers, and medical doctors who want to improve the therapeutic efficacy of small hydrophilic drugs.

multidisciplinary sciences
Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Siva Ram Munnangi,Ahmed Adel Ali Youssef,Nagarjuna Narala,Preethi Lakkala,Sagar Narala,Sateesh Kumar Vemula,Michael Repka

DOI: https://doi.org/10.1007/s11095-023-03517-w

IF: 4.58

2023-05-05

Pharmaceutical Research

Abstract:Despite numerous research efforts, drug delivery through the oral route remains a major challenge to formulation scientists. The oral delivery of drugs poses a significant challenge because more than 40% of new chemical entities are practically insoluble in water. Low aqueous solubility is the main problem encountered during the formulation development of new actives and for generic development. A complexation approach has been widely investigated to address this issue, which subsequently improves the bioavailability of these drugs. This review discusses the various types of complexes such as metal complex (drug-metal ion), organic molecules (drug-caffeine or drug-hydrophilic polymer), inclusion complex (drug-cyclodextrin), and pharmacosomes (drug-phospholipids) that improves the aqueous solubility, dissolution, and permeability of the drug along with the numerous case studies reported in the literature. Besides improving solubility, drug-complexation provides versatile functions like improving stability, reducing the toxicity of drugs, increasing or decreasing the dissolution rate, and enhancing bioavailability and biodistribution. Apart, various methods to predict the stoichiometric ratio of reactants and the stability of the developed complex are discussed.

pharmacology & pharmacy,chemistry, multidisciplinary
Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs

Isaïe Nyamba,Charles B Sombié,Moussa Yabré,Hermine Zimé-Diawara,Josias Yaméogo,Salfo Ouédraogo,Anna Lechanteur,Rasmané Semdé,Brigitte Evrard

DOI: https://doi.org/10.1016/j.ejpb.2024.114513

Abstract:High solubility in water and physiological fluids is an indispensable requirement for the pharmacological efficacy of an active pharmaceutical ingredient. Indeed, it is well established that pharmaceutical substances exhibiting limited solubility in water are inclined towards diminished and inconsistent absorption following oral administration, consequently resulting in variability in therapeutic outcomes. The current advancements in combinatorial chemistry and pharmaceutical design have facilitated the creation of drug candidates characterized by increased lipophilicity, elevated molecular size, and reduced aqueous solubility. Undoubtedly, the issue of poorly water-soluble medications has been progressively escalating over recent years. Indeed, 40% of the top 200 oral medications marketed in the United States, 33% of drugs listed in the US pharmacopoeia, 75% of compounds under development and 90% of new chemical entities are insufficiently water-soluble compounds. In order to address this obstacle, formulation scientists employ a variety of approaches, encompassing both physical and chemical methods such as prodrug synthesis, salt formation, solid dispersions formation, hydrotropic substances utilization, solubilizing agents incorporation, cosolvent addition, polymorphism exploration, cocrystal creation, cyclodextrins complexation, lipid formulations, particle size reduction and nanoformulation techniques. Despite the utilization of these diverse approaches, the primary reason for the failure in new drug development persists as the poor aqueous solubility of pharmaceutical compounds. This paper, therefore, delves into the foundational principles that underpin the implementation of various formulation strategies, along with a discussion on the respective advantages and drawbacks associated with each approach. Additionally, a discourse is provided regarding methodological frameworks for making informed decisions on selecting an appropriate formulation strategy to effectively tackle the key challenges posed during the development of a poorly water-soluble drug candidate.
Innovative medicinal chemistry strategies for enhancing drug solubility

Zhangxu He,Weiguang Yang,Feifei Yang,Jingyu Zhang,Liying Ma

DOI: https://doi.org/10.1016/j.ejmech.2024.116842

2024-12-05

Abstract:Drug candidates with poor solubility have been recognized as the cause of many drug development failures, owing to the fact that low solubility is unfavorable for physicochemical, pharmacokinetic (PK) and pharmacodynamic (PD) properties. Given the imperative role of solubility during drug development, we herein summarize various strategies for solubility optimizations from a medicinal chemistry perspective, including introduction of polar group, salt formation, structural simplification, disruption of molecular planarity and symmetry, optimizations on the solvent exposed region as well as prodrug design. In addition, methods for solubility assessment and prediction are reviewed. Besides, we have deeply discussed the strategies for solubility improvement. This paper is expected to be beneficial for the development of drug-like molecules with good solubility.
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

Kumari,Choudhari,Patel,Gupta,Singh,Rosenholm,Bansal,Kurmi

DOI: https://doi.org/10.3390/life13051099

2023-04-28

Life

Abstract:A drug's aqueous solubility is defined as the ability to dissolve in a particular solvent, and it is currently a major hurdle in bringing new drug molecules to the market. According to some estimates, up to 40% of commercialized products and 70–90% of drug candidates in the development stage are poorly soluble, which results in low bioavailability, diminished therapeutic effects, and dosage escalation. Because of this, solubility must be taken into consideration when developing and fabricating pharmaceutical products. To date, a number of approaches have been investigated to address the problem of poor solubility. This review article attempts to summarize several conventional methods utilized to increase the solubility of poorly soluble drugs. These methods include the principles of physical and chemical approaches such as particle size reduction, solid dispersion, supercritical fluid technology, cryogenic technology, inclusion complex formation techniques, and floating granules. It includes structural modification (i.e., prodrug, salt formation, co-crystallization, use of co-solvents, hydrotrophy, polymorphs, amorphous solid dispersions, and pH variation). Various nanotechnological approaches such as liposomes, nanoparticles, dendrimers, micelles, metal organic frameworks, nanogels, nanoemulsions, nanosuspension, carbon nanotubes, and so forth have also been widely investigated for solubility enhancement. All these approaches have brought forward the enhancement of the bioavailability of orally administered drugs by improving the solubility of poorly water-soluble drugs. However, the solubility issues have not been completely resolved, owing to several challenges associated with current approaches, such as reproducibility in large scale production. Considering that there is no universal approach for solving solubility issues, more research is needed to simplify the existing technologies, which could increase the number of commercially available products employing these techniques.

biology
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics

Bhalani,Nutan,Kumar,Singh Chandel

DOI: https://doi.org/10.3390/biomedicines10092055

IF: 4.757

2022-08-24

Biomedicines

Abstract:The low water solubility of pharmacoactive molecules limits their pharmacological potential, but the solubility parameter cannot compromise, and so different approaches are employed to enhance their bioavailability. Pharmaceutically active molecules with low solubility convey a higher risk of failure for drug innovation and development. Pharmacokinetics, pharmacodynamics, and several other parameters, such as drug distribution, protein binding and absorption, are majorly affected by their solubility. Among all pharmaceutical dosage forms, oral dosage forms cover more than 50%, and the drug molecule should be water-soluble. For good therapeutic activity by the drug molecule on the target site, solubility and bioavailability are crucial factors. The pharmaceutical industry's screening programs identified that around 40% of new chemical entities (NCEs) face various difficulties at the formulation and development stages. These pharmaceuticals demonstrate less solubility and bioavailability. Enhancement of the bioavailability and solubility of drugs is a significant challenge in the area of pharmaceutical formulations. According to the Classification of Biopharmaceutics, Class II and IV drugs (APIs) exhibit poor solubility, lower bioavailability, and less dissolution. Various technologies are discussed in this article to improve the solubility of poorly water-soluble drugs, for example, the complexation of active molecules, the utilization of emulsion formation, micelles, microemulsions, cosolvents, polymeric micelle preparation, particle size reduction technologies, pharmaceutical salts, prodrugs, the solid-state alternation technique, soft gel technology, drug nanocrystals, solid dispersion methods, crystal engineering techniques and nanomorph technology. This review mainly describes several other advanced methodologies for solubility and bioavailability enhancement, such as crystal engineering, micronization, solid dispersions, nano sizing, the use of cyclodextrins, solid lipid nanoparticles, colloidal drug delivery systems and drug conjugates, referring to a number of appropriate research reports.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Editorial: Persistent Endeavors for the Enhancement of Dissolution and Oral Bioavailability

Wei Wu,Yi Lu,Jianping Qi

DOI: https://doi.org/10.1016/j.apsb.2019.01.009

IF: 14.903

2019-01-01

Acta Pharmaceutica Sinica B

Abstract:More than 50%of marketed drugs and 90%drug candidates are believed to be poorly water-soluble, and these figures keep growing due to input of new drug entities into the pool, thanks to the fast development in drug discovery. It has long been recognized that poor solubility poses problems of retarded dissolution rate and thereby poor bioavailability. Enhancement of dissolution and oral bioavailability remains a challenge not only in
Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

Hongge Wang,Peixu Zhao,Ruilong Ma,Jirun Jia,Qiang Fu

DOI: https://doi.org/10.1016/j.drudis.2024.103883

IF: 8.369

2024-01-16

Drug Discovery Today

Abstract:Overcoming the poor water solubility of small-molecule drugs is a major challenge in the development of clinical pharmaceuticals. Amorphization of crystalline drugs is a highly effective strategy to improve their aqueous solubility. However, amorphous drugs are thermodynamically unstable and likely to crystallize during manufacturing and storage. Recently, drug-drug co-amorphous systems have emerged as a novel strategy to not only enable enhanced dissolution and physical stability of the...

pharmacology & pharmacy
Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs

Tahir Mahmood,Rai M Sarfraz,Asmara Ismail,Muhammad Ali,Abdur Rauf Khan

DOI: https://doi.org/10.1089/adt.2022.119

Abstract:Low water solubility is the main hindrance in the growth of pharmaceutical industry. Approximately 90% of newer molecules under investigation for drugs and 40% of novel drugs have been reported to have low water solubility. The key and thought-provoking task for the formulation scientists is the development of novel techniques to overcome the solubility-related issues of these drugs. The main intention of present review is to depict the conventional and novel strategies to overcome the solubility-related problems of Biopharmaceutical Classification System Class-II drugs. More than 100 articles published in the last 5 years were reviewed to have a look at the strategies used for solubility enhancement. pH modification, salt forms, amorphous forms, surfactant solubilization, cosolvency, solid dispersions, inclusion complexation, polymeric micelles, crystals, size reduction, nanonization, proliposomes, liposomes, solid lipid nanoparticles, microemulsions, and self-emulsifying drug delivery systems are the various techniques to yield better bioavailability of poorly soluble drugs. The selection of solubility enhancement technique is based on the dosage form and physiochemical characteristics of drug molecules.
Improving solubility of poorly water-soluble drugs by protein-based strategy: A review

Xiaowen Liu,Limin Zhao,Baojian Wu,Fener Chen

DOI: https://doi.org/10.1016/j.ijpharm.2023.122704

IF: 6.51

2023-01-01

International Journal of Pharmaceutics

Abstract:Poorly water-soluble drugs are frequently encountered and present a most challengeable difficulty in pharma-ceutical development. Poor solubility of drugs can lead to suboptimal bioavailability and therapeutic efficiency. Increasing efforts have been contributed to improve the solubility of poorly water-soluble drugs for better pharmacokinetics and pharmacodynamics. Among various solubility enhancement technologies, protein-based strategy to address poorly water-soluble drugs issues has special interests for natural advantages including versatile interactions between proteins and hydrophobic drugs, biocompatibility, biodegradation, and metabo-lization of proteins. The protein-drug formulations could be formed by covalent conjugations or noncovalent interactions to facilitate solubility of poorly water-soluble drugs. This review is to summarize the advances using proteins including plant proteins, mammalian proteins, and recombinant proteins, to enhance water solubility of poorly water-soluble drugs.
Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs

Manisha Saini,Shailender Bhatt,Harish Dureja,Neeta Solanki

DOI: https://doi.org/10.2174/0118722105229356231030065938

2023-11-02

Abstract:Background: In the development of drug delivery systems, drugs' solubility remains the most challenging constraint. Many newly synthesized chemical compounds are available, but they involve low solubility and poor permeability restrictions. Among various drug delivery systems, the utilization of solid dispersion technologies has become more focused due to their promising benefits. Objective: This technology has attracted extensive attention for dissolution rate improvement along with substantial bioavailability enhancement of poorly water-soluble drug candidates. Methods: Many approaches have been employed for preparing solid dispersions, such as the melting method, hot melt extrusion, solvent evaporation process, fusion and kneading method, spray drying technique, co-grinding and freeze drying, supercritical fluid technology, etc. Result: A wide variety of hydrophilic and hydrophobic materials are available as carriers, which are employed in the formulation of solid dispersions. Depending on the carrier characteristics, immediate- release solid dispersions and/or controlled-release solid dispersions can be formulated. Multiple hydrophilic materials have been explored for heightening dissolution features with enhanced bioavailability of poorly water-soluble drug molecules. The availability of commercially available products further validates the utility of solid dispersion technology in drug delivery systems. Conclusion: In the current manuscript, an attempt has been made to highlight the comprehensive development techniques, characterization techniques, recent solid dispersion technologies, clinical trial studies, and patented technology, along with studies heightening the dissolution behavior of numerous poorly aqueous soluble drugs. The major stability issues affecting the suitability of solid dispersions are also discussed.
Development of Liquisolid Technology to Overcome Dissolution/Absorption Limitations of Oral Drugs

Huan Wang,Xingwang Zhang

DOI: https://doi.org/10.1055/s-0044-1788984

2024-09-01

Pharmaceutical Fronts

Abstract:Increasing influx of poorly water-soluble drugs poses a significant challenge to oral drug delivery. Conventional solubilization techniques such as solid dispersion and cyclodextrin inclusion, while capable of improving drug dissolution, suffer from a great predicament in subsequent formulation processing. A novel "powder solution technology," the liquisolid technique, has come to the forefront in dealing with drug solubilization and formulation of oral "problem" drugs. The liquisolid technique involves the adsorption of liquid medications onto suitable carrier and coating materials, followed by conversion into free-flowing, dry-looking, and compressible powders. In the liquisolid system, the drug is dispersed in an almost molecular state, which greatly contributes to drug dissolution and absorption. This review aims to present the fundamentals of liquisolid technology and update the concept of liquisolid processing to expand its applications. The trend of modern drug discovery, drug solubilization approaches, application of liquisolid technology in formulation innovation, formulation composition, and design of liquisolid systems were discussed in detail. Special emphasis was placed on the application of liquisolid technology to improve the dissolution and bioavailability of poorly water-soluble drugs. Accumulating evidence shows that the liquisolid technology has immense potential to improve oral delivery and facilitate the secondary development of insoluble drugs. Received: 15 September 2023 Accepted: 24 July 2024 Article published online: 29 August 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Nanonization techniques to overcome poor water-solubility with drugs

Flávia Lidiane Oliveira Da Silva,Maria Betânia De Freitas Marques,Kelly Cristina Kato,Guilherme Carneiro

DOI: https://doi.org/10.1080/17460441.2020.1750591

Abstract:Introduction: Most drugs used in therapy have low water-solubility, a factor that could reduce their dissolution rate and oral bioavailability, representing a challenge in pharmaceutical development. Nanonization of drugs is the reduction of particles to nanoscale, increasing the surface area and consequently the saturation solubility and dissolution rate and resulting in higher bioavailability. Areas covered: This review provides an overview of the consequences of the poor water-solubility and the main strategies applied to increase the solubility of poorly water-soluble drugs. The relationship between the biopharmaceutical classification system and the solubilization process of the drug is also considered. Finally, it includes how drug nanoparticles and nanocarriers, especially lipid-based nanosystems, can overcome these challenges and which of these approaches are already available on the market. Expert opinion: Due to the growing importance of nanomedicines, especially for applications in poorly water-soluble drugs, it is important to clearly establish the specifications and quality criteria for nanonized drugs to ensure the quality and safety of nanoparticles.
Insight into Delivery Approaches for Biopharmaceutics Classification System Class II and IV Drugs

Shashank Chaturvedi,Raghav Mishra

DOI: https://doi.org/10.2174/2210303110999200712185109

2020-11-20

Drug Delivery Letters

Abstract:: Formulation development of BCS Class II and IV drugs is a challenging task due to their poor solubility and permeability issue. : An extensive literature survey was conducted to explore the relevant pharmaceutical approaches that have been used for solving the issue of poor solubility and permeability in the recent past. : It has been found that a plethora of approaches have been investigated for addressing the issue of poor solubility and or permeability. These include physical modifications (modification of crystal habit, particle size reduction, complexation, polymorphism and drug dispersion in carriers), chemical modifications (salt formation), and formulation modifications (Nanotechnology-based approaches and hydrotropy). : The physical and chemical modification approaches can be effectively used to enhance the solubility and dissolution rate of poorly soluble drugs, but the additional problem of poor permeability has been better addressed by lipid-based drug delivery systems. As the latter presents the drug in the solubilized state, bypass first-pass effects, circumvent the effect of Para-glycoprotein mediated efflux of drugs, hence contributing to overall bioavailability enhancement.
Enhancing the Bioavailability of Poorly Soluble Drugs

Rodolfo Pinal

DOI: https://doi.org/10.3390/pharmaceutics16060758

IF: 6.525

2024-06-05

Pharmaceutics

Abstract:The poor aqueous solubility of drugs is such a frequent challenge to drug absorption, bioavailability, and drug delivery that it is occasionally spoken about as an "unwritten rule" in drug product development [...]

pharmacology & pharmacy
Solubility Enhancement of Poorly Water-Soluble Drugs by Solid Dispersion Techniques

Vishal Gupta,Sokindra Kumar,Rajesh Agrawal

DOI: https://doi.org/10.48165/ijppronline.2023.14407

2023-11-15

Abstract:The fact that newly discovered API’s (about 90%) or new molecular entity (NME) have little or poor aqueous solubility, causes a significant challenges to the initialization of development and commercialization of dosage form at the manufacturing facility. Poor aqueous solubility of API’s has critical role in drug dissolution or availability of drug at the site of actionor bioavailability, when a dosage form is administered orally. Various techniques are available for the enhancement of solubility but all individual techniques have its own limitations for commercialization. The known Solubility enhancement techniques like Solid dispersions involved the dispersion of poorly soluble drug in a suitable inert carrier at a molecular level and form amorphous and highly soluble compounds. The conversion of compound in to amorphous form or reduction of particle size to its molecular level caused enhanced solubility of poorly soluble by the application of solid dispersion techniques.
Improvement in solubility of poor water-soluble drugs by solid dispersion

Swati Sareen,George Mathew,Lincy Joseph

DOI: https://doi.org/10.4103/2230-973x.96921

2012-01-01

International Journal of Pharmaceutical Investigation

Abstract:This article is intended to combine recent literature on solid dispersion technology for solubility enhancement with special emphasis on mechanism responsible for the same by solid dispersion, various preparation methods, and evaluation parameters. Solubility behavior is the most challenging aspect for various new chemical entities as 60% of the new potential products possess solubility problems. This is the biggest reason for new drug molecules not reaching to the market or not reaches to full potential. There are various techniques to enhance the drug solubility such as particle size reduction, nanosuspension, use of surfactants, salt formation, solid dispersion, etc. From this article it may be concluded that solid dispersion is an important approach for improvement of bioavailability of poor water-soluble drugs.
Self-Microemulsion Technology for Water-Insoluble Drug Delivery

Beibei Yan,Yu Gu,Juan Zhao,Yangyang Liu,Lulu Wang,Yancai Wang

DOI: https://doi.org/10.2174/1573413715666190112122107

IF: 1.513

2019-01-01

Current Nanoscience

Abstract:According to the drug discovery, approximately 40% of the new chemical entities show poor bioavailability due to their low aqueous solubility. In order to increase the solubility of the drugs, self-micro emulsifying drug delivery systems (SMEDDS) are considered as an ideal technology for enhancing the permeability of poorly soluble drugs in GI membranes. The SMEDDS are also generally used to enhance the oral bioavailability of the hydrophobic drugs. At present, most of the self-microemulsion drugs are liquid dosage forms, which could cause some disadvantages, such as the low bioavailability of the traditional liquid SMEDDS. Therefore, solid self-micro emulsifying drug delivery systems (S-SMEDDS) have emerged widely in recent years, which were prepared by solidifying a semi-solid or liquid self-emulsifying (SE) ingredient into a powder in order to improve stability, treatment and patient compliance. The article gives a comprehensive introduction of the study of SMEDDS which could effectively tackle the problem of the water-insoluble drug, especially the development of solidification technology of SMEDDS. Finally, the present challenges and the prospects in this field were also discussed.
Advances in Lipid-Based Drug Delivery: Enhancing Efficiency for Hydrophobic Drugs

Gang Wang,Junjie Wang,Wei Wu,Suet To,Hua Zhao,Jing Wang

DOI: https://doi.org/10.1517/17425247.2015.1021681

2015-01-01

Expert Opinion on Drug Delivery

Abstract:Many drug candidates with high therapeutic efficacy have low water solubility, which limits the administration and transport across physiological barriers, for example, the tumor tissue barrier. Therefore, strategies are needed to permeabilize the physiological barriers safely so that hydrophobic drugs may be delivered efficiently.This review focuses on prospects for therapeutic application of lipid-based drug delivery carriers that increase hydrophobic drugs to improve their solubility, bioavailability, drug release, targeting and absorption. Moreover, novel techniques to prepare for lipid-based drug delivery to extend pharmaceuticals with poor bioavailability such as surface modifications of lipid-based drug delivery are presented. Industrial developments of several drug candidates employing these strategies are discussed, as well as applications and clinical trials.Overall, hydrophobic drugs can be encapsulated in the lipid-based drug delivery systems, represent a relatively safe and promising strategy to extend drug retention, lengthen the lifetime in the circulation, and allow active targeting to specific tissues and controllable drug release in the desirable sites. However, there are still noticeable gaps that need to be filled before the theoretical advantage of these formulations may truly be realized such as investigation on the use of lipid-based drug delivery for administration routes. This research may provide further interest within the area of lipid-based systems, both in industry and in the clinic.

Drug Delivery Strategies for Insoluble Drugs

Insoluble drug delivery strategies: review of recent advances and business prospects

Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs

Innovative medicinal chemistry strategies for enhancing drug solubility

Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics

Editorial: Persistent Endeavors for the Enhancement of Dissolution and Oral Bioavailability

Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs

Improving solubility of poorly water-soluble drugs by protein-based strategy: A review

Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs

Development of Liquisolid Technology to Overcome Dissolution/Absorption Limitations of Oral Drugs

Nanonization techniques to overcome poor water-solubility with drugs

Insight into Delivery Approaches for Biopharmaceutics Classification System Class II and IV Drugs

Enhancing the Bioavailability of Poorly Soluble Drugs

Solubility Enhancement of Poorly Water-Soluble Drugs by Solid Dispersion Techniques

Improvement in solubility of poor water-soluble drugs by solid dispersion

Self-Microemulsion Technology for Water-Insoluble Drug Delivery

Advances in Lipid-Based Drug Delivery: Enhancing Efficiency for Hydrophobic Drugs